140 related articles for article (PubMed ID: 20160392)
21. Risk of cardiovascular disease in kidney donors as a chronic kidney disease cohort.
Naganuma T; Takemoto Y; Taiyou O; Hirokazu T; Masaki M; Maeda S; Nakatani T
Mol Med Rep; 2012 Jan; 5(1):7-11. PubMed ID: 21993905
[TBL] [Abstract][Full Text] [Related]
22. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
23. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
[TBL] [Abstract][Full Text] [Related]
24. Kidney dysfunction, cardiorespiratory fitness, and the risk of death in women.
Gulati M; Black HR; Arnsdorf MF; Shaw LJ; Bakris GL
J Womens Health (Larchmt); 2012 Sep; 21(9):917-24. PubMed ID: 22480201
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease.
Hanatani S; Izumiya Y; Onoue Y; Tanaka T; Yamamoto M; Ishida T; Yamamura S; Kimura Y; Araki S; Arima Y; Nakamura T; Fujisue K; Takashio S; Sueta D; Sakamoto K; Yamamoto E; Kojima S; Kaikita K; Tsujita K
Int J Cardiol; 2018 Oct; 268():216-221. PubMed ID: 29650344
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
27. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
[TBL] [Abstract][Full Text] [Related]
28. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
Drożdż T; Kwinta P; Kordon Z; Sztefko K; Rudziński A; Zachwieja K; Miklaszewska M; Czarnecka D; Drożdż D
Pol Merkur Lekarski; 2018 Apr; 44(262):171-176. PubMed ID: 29775443
[TBL] [Abstract][Full Text] [Related]
29. Plasma levels of natriuretic peptides and development of chronic kidney disease.
Ogawa N; Komura H; Kuwasako K; Kitamura K; Kato J
BMC Nephrol; 2015 Oct; 16():171. PubMed ID: 26499263
[TBL] [Abstract][Full Text] [Related]
30. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
Takase H; Dohi Y
Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
[TBL] [Abstract][Full Text] [Related]
31. Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients.
Carr SJ; Bavanandan S; Fentum B; Ng L
Clin Sci (Lond); 2005 Jul; 109(1):75-82. PubMed ID: 15743271
[TBL] [Abstract][Full Text] [Related]
32. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
[TBL] [Abstract][Full Text] [Related]
33. Increase Trend in Home Blood Pressure on a Single Occasion Is Associated With B-Type Natriuretic Peptide and the Estimated Glomerular Filtration Rate.
Shibasaki S; Hoshide S; Eguchi K; Ishikawa J; Kario K;
Am J Hypertens; 2015 Sep; 28(9):1098-105. PubMed ID: 25631382
[TBL] [Abstract][Full Text] [Related]
34. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y
J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914
[TBL] [Abstract][Full Text] [Related]
36. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
37. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease.
Bjurman C; Petzold M; Venge P; Farbemo J; Fu ML; Hammarsten O
Clin Biochem; 2015 Mar; 48(4-5):302-7. PubMed ID: 25637776
[TBL] [Abstract][Full Text] [Related]
38. Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction.
Hayashi M; Yasuda Y; Suzuki S; Tagaya M; Ito T; Kamada T; Yoshinaga M; Sugishita Y; Fujiwara W; Yokoi H; Ozaki Y; Izawa H
Heart Vessels; 2017 Mar; 32(3):279-286. PubMed ID: 27385024
[TBL] [Abstract][Full Text] [Related]
39. Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes.
Bello AK; Hemmelgarn B; Lloyd A; James MT; Manns BJ; Klarenbach S; Tonelli M;
Clin J Am Soc Nephrol; 2011 Jun; 6(6):1418-26. PubMed ID: 21527648
[TBL] [Abstract][Full Text] [Related]
40. Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease.
Li X; Yang XC; Sun QM; Chen XD; Li YC
Chin Med J (Engl); 2013 Mar; 126(5):823-7. PubMed ID: 23489784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
